Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Armistice Capital, LLC | 1,313,348 9.990% | 234,889 (+21.78%) | Filing History |
| 2024-02-14 6:00 pm Unchanged | 2023-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Ikarian Capital LLC | 448,101 4.600% | 0 (Unchanged) | Filing History |
| 2024-02-14 2:23 pm Purchase | 2023-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Armistice Capital, LLC | 1,078,459 9.990% | 122,464 (+12.81%) | Filing History |
| 2023-11-24 1:43 pm Purchase | 2023-11-21 | 13D | Bellicum Pharmaceuticals, Inc. BLCM | BAKER BROS. ADVISORS LP | 2,365,472 19.990% | 167,553 (+7.62%) | Filing History |
| 2023-05-05 4:24 pm Purchase | 2023-05-05 | 13D | Bellicum Pharmaceuticals, Inc. BLCM | BAKER BROS. ADVISORS LP | 2,197,919 19.990% | 2,197,919 (New Position) | Filing History |
| 2023-02-14 12:06 pm Purchase | 2022-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Armistice Capital, LLC | 955,995 9.990% | 23,943 (+2.57%) | Filing History |
| 2023-02-14 11:02 am Sale | 2022-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Ikarian Capital LLC | 448,101 5.200% | -48,655 (-9.79%) | Filing History |
| 2023-02-09 11:07 am Sale | 2022-12-30 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | VANGUARD GROUP INC | 181,843 2.110% | -248,235 (-57.72%) | Filing History |
| 2022-11-18 3:01 pm Purchase | 2022-09-30 | 13D | Bellicum Pharmaceuticals, Inc. BLCM | BELLICUM PHARMACEUTICALS INC BLCM | 691,639 7.400% | 691,639 (New Position) | Filing History |
| 2022-02-14 6:31 pm Purchase | 2021-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Armistice Capital, LLC | 932,052 9.990% | 491,308 (+111.47%) | Filing History |
| 2022-02-14 4:32 pm Sale | 2021-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Ikarian Capital LLC | 496,756 5.900% | -3,244 (-0.65%) | Filing History |
| 2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | VANGUARD GROUP INC | 430,078 5.120% | 430,078 (New Position) | Filing History |
| 2021-02-16 5:10 pm Sale | 2020-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Armistice Capital, LLC | 440,744 8.000% | -1,309,256 (-74.81%) | Filing History |
| 2021-02-16 4:37 pm Sale | 2020-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Boxer Capital LLC | 265,743 4.990% | -247,617 (-48.23%) | Filing History |
| 2021-02-10 3:57 pm Purchase | 2020-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Renaissance Technologies LLC | 26,631 0.530% | 26,631 (New Position) | Filing History |
| 2021-01-08 9:57 pm Purchase | 2020-12-24 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Ikarian Capital LLC | 500,000 9.900% | 500,000 (New Position) | Filing History |